139 related articles for article (PubMed ID: 34695715)
21. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
[TBL] [Abstract][Full Text] [Related]
22. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Pabinger I; van Es N; Heinze G; Posch F; Riedl J; Reitter EM; Di Nisio M; Cesarman-Maus G; Kraaijpoel N; Zielinski CC; Büller HR; Ay C
Lancet Haematol; 2018 Jul; 5(7):e289-e298. PubMed ID: 29885940
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer.
Li Z; Zhang G; Zhang M; Mei J; Weng H; Peng Z
Clin Appl Thromb Hemost; 2020; 26():1076029620910793. PubMed ID: 32162530
[TBL] [Abstract][Full Text] [Related]
24. [Predicting the Incidence of Venous Thromboembolism Using the Khorana Score: A Literature Review].
Nishimura A; Ikeda Y
Yakugaku Zasshi; 2021; 141(4):611-622. PubMed ID: 33790126
[TBL] [Abstract][Full Text] [Related]
25. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
26. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
[TBL] [Abstract][Full Text] [Related]
27. The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study.
Zhang L; Liu X; Yang R; Yang Y; Chen X
Mediators Inflamm; 2022; 2022():9215311. PubMed ID: 36046761
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
Bjørnhart B; Kristiansen C; Asmussen J; Hansen KH; Wedervang K; Jørgensen TL; Herrstedt J; Schytte T
Thromb Res; 2023 Jan; 221():164-172. PubMed ID: 36396518
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients.
He X; Wei SN; Qin WW; Geng N; Li B; Song S; Wang P
Expert Rev Hematol; 2023; 16(12):1135-1142. PubMed ID: 37883026
[TBL] [Abstract][Full Text] [Related]
30. Prediction of venous thromboembolism in cancer patients.
Ay C; Dunkler D; Marosi C; Chiriac AL; Vormittag R; Simanek R; Quehenberger P; Zielinski C; Pabinger I
Blood; 2010 Dec; 116(24):5377-82. PubMed ID: 20829374
[TBL] [Abstract][Full Text] [Related]
31. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
[TBL] [Abstract][Full Text] [Related]
32. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
33. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
Sanfilippo KM; Carson KR; Wang TF; Luo S; Edwin N; Kuderer N; Keller JM; Gage BF
Res Pract Thromb Haemost; 2022 Jan; 6(1):e12634. PubMed ID: 35028491
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors of lung cancer complicated with symptomatic venous thromboembolism].
Gong CY; Li ZW; Zhou DX; Yan H; Bao J; Ye RJ; Cao ZL; Gao ZC; Mu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):454-8. PubMed ID: 27289575
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
38. Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model.
Di W; Xu H; Ling C; Xue T
Thromb J; 2023 Sep; 21(1):95. PubMed ID: 37710256
[TBL] [Abstract][Full Text] [Related]
39. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
